Heron Therapeutics (HRTX) Revenue & Revenue Breakdown

Overview ForecastOwnership Financials Chart Transcripts

Heron Therapeutics Revenue Highlights

Latest Revenue (Y)

$144.28M

Latest Revenue (Q)

$38.90M

Main Segment (Y)

C I N V A N T I

Heron Therapeutics Revenue by Period

Heron Therapeutics Revenue by Year

Date	Revenue	Change
2024-12-31	$144.28M	13.57%
2023-12-31	$127.04M	17.99%
2022-12-31	$107.67M	24.70%
2021-12-31	$86.35M	-2.59%
2020-12-31	$88.64M	-39.28%
2019-12-31	$145.97M	88.41%
2018-12-31	$77.47M	151.81%
2017-12-31	$30.77M	2305.55%
2016-12-31	$1.28M	100.00%
2015-12-31	-	100.00%
2014-12-31	-	100.00%
2013-12-31	-	100.00%
2012-12-31	-	-100.00%
2011-12-31	$646.00K	-50.35%
2010-12-31	$1.30M	3.17%
2009-12-31	$1.26M	241.73%
2008-12-31	$369.00K	-10.44%
2007-12-31	$412.00K	100.00%
2006-12-31	-	-100.00%
2005-12-31	$5.39M	-0.24%
2004-12-31	$5.40M	11.47%
2003-12-31	$4.85M	-16.63%
2002-12-31	$5.82M	32.54%
2001-12-31	$4.39M	30.35%
2000-12-31	$3.37M	-83.50%
1999-12-31	$20.40M	2.00%
1998-12-31	$20.00M	9.29%
1997-12-31	$18.30M	-2.14%
1996-12-31	$18.70M	16.15%
1995-12-31	$16.10M	1.26%
1994-12-31	$15.90M	-20.10%
1993-12-31	$19.90M	-

Heron Therapeutics generated $144.28M in revenue during NA 2024, up 13.57% compared to the previous quarter, and up 98.85% compared to the same period a year ago.

Heron Therapeutics Revenue by Quarter

Date	Revenue	Change
2025-03-31	$38.90M	-4.61%
2024-12-31	$40.78M	24.29%
2024-09-30	$32.81M	-8.92%
2024-06-30	$36.02M	3.91%
2024-03-31	$34.67M	1.28%
2023-12-31	$34.23M	8.90%
2023-09-30	$31.43M	-1.03%
2023-06-30	$31.76M	7.25%
2023-03-31	$29.61M	-1.38%
2022-12-31	$30.03M	13.07%
2022-09-30	$26.56M	-3.88%
2022-06-30	$27.63M	17.79%
2022-03-31	$23.46M	13.57%
2021-12-31	$20.66M	-11.08%
2021-09-30	$23.23M	3.51%
2021-06-30	$22.44M	12.11%
2021-03-31	$20.02M	-2.85%
2020-12-31	$20.61M	3.21%
2020-09-30	$19.96M	-11.92%
2020-06-30	$22.67M	-10.76%
2020-03-31	$25.40M	-27.60%
2019-12-31	$35.08M	-17.69%
2019-09-30	$42.62M	16.27%
2019-06-30	$36.66M	16.00%
2019-03-31	$31.60M	9.56%
2018-12-31	$28.84M	45.78%
2018-09-30	$19.79M	14.52%
2018-06-30	$17.28M	49.36%
2018-03-31	$11.57M	15.06%
2017-12-31	$10.05M	17.28%
2017-09-30	$8.57M	0.73%
2017-06-30	$8.51M	134.31%
2017-03-31	$3.63M	183.97%
2016-12-31	$1.28M	93.49%
2016-09-30	$661.00K	100.00%
2016-06-30	-	100.00%
2016-03-31	-	100.00%
2015-12-31	-	100.00%
2015-09-30	-	100.00%
2015-06-30	-	100.00%
2015-03-31	-	100.00%
2014-12-31	-	100.00%
2014-09-30	-	100.00%
2014-06-30	-	100.00%
2014-03-31	-	100.00%
2013-12-31	-	100.00%
2013-09-30	-	100.00%
2013-06-30	-	100.00%
2013-03-31	-	100.00%
2012-12-31	-	100.00%
2012-09-30	-	100.00%
2012-06-30	-	100.00%
2012-03-31	-	100.00%
2011-12-31	-	100.00%
2011-09-30	-	-100.00%
2011-06-30	$251.00K	-36.46%
2011-03-31	$395.00K	120.67%
2010-12-31	$179.00K	-49.00%
2010-09-30	$351.00K	-33.77%
2010-06-30	$530.00K	119.92%
2010-03-31	$241.00K	97.54%
2009-12-31	$122.00K	-89.08%
2009-09-30	$1.12M	7878.57%
2009-06-30	$14.00K	75.00%
2009-03-31	$8.00K	-61.90%
2008-12-31	$21.00K	-67.19%
2008-09-30	$64.00K	-57.89%
2008-06-30	$152.00K	14.29%
2008-03-31	$133.00K	0.76%
2007-12-31	$132.00K	-

Heron Therapeutics generated $38.90M in revenue during Q1 2025, up -4.61% compared to the previous quarter, and up 113.64% compared to the same period a year ago.

Heron Therapeutics Revenue Breakdown

Heron Therapeutics Revenue Breakdown by Product

Annual Revenue by Product

Product/Service	Dec 24	Dec 23	Dec 22	Dec 21	Dec 20
S U S T O L	$14.14M	$13.06M	$10.23M	$9.91M	$800.00K
C I N V A N T I	$100.08M	$94.87M	$87.25M	$73.51M	$87.80M
Z Y N R E L E F	$25.55M	$17.73M	$10.20M	$2.92M	-

Heron Therapeutics's latest annual revenue breakdown by segment (product or service), as of Dec 24: C I N V A N T I (71.60%), Z Y N R E L E F (18.28%), and S U S T O L (10.12%).

Quarterly Revenue by Product

Product/Service	Jun 25	Mar 25	Dec 24	Sep 24	Mar 24	Dec 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20
C I N V A N T I	$24.14M	$25.74M	$51.80M	$22.66M	$25.62M	$47.54M	$24.47M	$22.86M	$23.07M	$21.17M	$22.66M	$20.30M	$17.31M	$18.00M	$19.70M	$18.50M	$20.20M	$19.80M	$22.60M	$25.20M
Z Y N R E L E F	$8.19M	$8.04M	$14.29M	$6.25M	$5.01M	$10.07M	$4.13M	$3.53M	$3.90M	$2.72M	$2.52M	$1.10M	$824.00K	$2.10M	-	-	-	-	-	-
S U S T O L	$2.40M	$2.86M	$7.76M	$2.76M	$3.62M	$7.24M	$2.84M	$2.98M	$3.05M	$2.67M	$2.45M	$2.10M	$2.52M	$3.10M	$2.70M	$1.50M	$400.00K	$200.00K	$100.00K	$200.00K

Heron Therapeutics's latest quarterly revenue breakdown by segment (product or service), as of Jun 25: C I N V A N T I (69.50%), Z Y N R E L E F (23.57%), and S U S T O L (6.92%).

Heron Therapeutics Revenue Breakdown by Country

Quarterly Revenue by Country

Country	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19
Z Y N R E L E F	$3.53M	$3.90M	$2.72M	$2.52M	$1.10M	$824.00K	$2.10M	-	-	-	-	-	-	-	-
S U S T O L	$2.98M	$3.05M	$2.67M	$2.45M	$2.10M	$2.52M	$3.10M	$2.70M	$1.50M	$400.00K	$200.00K	$100.00K	$200.00K	$500.00K	$6.20M
C I N V A N T I	$22.86M	$23.07M	$21.17M	$22.66M	$20.30M	$17.31M	$18.00M	$19.70M	$18.50M	$20.20M	$19.80M	$22.60M	$25.20M	$34.60M	$36.40M

Heron Therapeutics's latest quarterly revenue breakdown by geography, as of Mar 23: C I N V A N T I (77.81%), Z Y N R E L E F (12.03%), and S U S T O L (10.16%).

Heron Therapeutics Peer Comparison by Revenue

Ticker	Company	Last Year Revenue	Last Quarter Revenue
CHRS	Coherus Oncology	$266.96M	$7.60M
HRTX	Heron Therapeutics	$144.28M	$38.90M
CDXS	Codexis	$59.34M	$7.54M
SGMO	Sangamo Therapeutics	$57.80M	$6.44M
CGEN	Compugen	$33.46M	$2.56M
OABI	OmniAb	$26.39M	$4.15M
MDWD	MediWound	$18.69M	$4.96M
PYXS	Pyxis Oncology	$16.15M	-
GNLX	Genelux	$8.00K	-
CRBP	Corbus Pharmaceuticals	-	-
TARA	Protara Therapeutics	-	-

HRTX Revenue FAQ

What is Heron Therapeutics’s yearly revenue?

Heron Therapeutics's yearly revenue for 2024 was $144.28M, representing an increase of 13.57% compared to 2023. The company's yearly revenue for 2023 was $127.04M, representing an increase of 17.99% compared to 2022. HRTX's yearly revenue for 2022 was $107.67M, representing an increase of 24.70% compared to 2021.

What is Heron Therapeutics’s quarterly revenue?

Heron Therapeutics's quarterly revenue for Q1 2025 was $38.9M, a -4.61% decrease from the previous quarter (Q4 2024), and a 12.21% increase year-over-year (Q1 2024). The company's quarterly revenue for Q4 2024 was $40.78M, a 24.29% increase from the previous quarter (Q3 2024), and a 19.13% increase year-over-year (Q4 2023). HRTX's quarterly revenue for Q3 2024 was $32.81M, a -8.92% decrease from the previous quarter (Q2 2024), and a 4.38% increase year-over-year (Q3 2023).

What is Heron Therapeutics’s revenue growth rate?

Heron Therapeutics's revenue growth rate for the last 3 years (2022-2024) was 34.00%, and for the last 5 years (2020-2024) was 62.78%.

What are Heron Therapeutics’s revenue streams?

Heron Therapeutics's revenue streams in c 24 are S U S T O L, C I N V A N T I, and Z Y N R E L E F. S U S T O L generated $14.14M in revenue, accounting 10.12% of the company's total revenue, up 8.31% year-over-year. C I N V A N T I generated $100.08M in revenue, accounting 71.60% of the company's total revenue, up 5.49% year-over-year. Z Y N R E L E F generated $25.55M in revenue, accounting 18.28% of the company's total revenue, up 44.11% year-over-year.

What is Heron Therapeutics’s main source of revenue?

For the fiscal year ending Dec 24, the largest source of revenue of Heron Therapeutics was C I N V A N T I. This segment made a revenue of $100.08M, representing 71.60% of the company's total revenue.